Patents by Inventor Judit Bajnogel

Judit Bajnogel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-?2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives
    Patent number: 5942506
    Abstract: This invention relates to new 1-?2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said benzodiazepine derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The compounds according to the invention correspond to the general formula (I), ##STR1## wherein the variables are herein below defined, and the compounds possess central nervous activities.
    Type: Grant
    Filed: February 9, 1996
    Date of Patent: August 24, 1999
    Assignee: GIS Gyogyszergyar Rt.
    Inventors: Pal Vago, Jozsef Reiter, Istvan Gyertyan, Istvan Gacsalyi, Andras Bilkei-Gorzo, Andras Egyed, Ferenc Andrasi, Anna Bakonyi, Pal Berzsenyi, Hilda Botka, Tamas Hamori, Cecilia Salamon Haskane, Edit Horvath, Katalin Horvath, Peter Korosi, Gyorgyne Mate, Imre Moravcsik, Eszter Szentkuti, Gabor Zolyomi, Gabor Blasko, Klara Daroczi Kazone, Gyula Simig, Karoly Tihanyi, Judit Bajnogel
  • Trisubstituted cycloalkane derivatives and process for the preparation thereof
    Patent number: 5523303
    Abstract: The invention relates to novel, pharmaceutically active trisubstituted cycloalkane derivatives, a process for the preparation thereof and pharmaceutical compositions comprising the same. The invention also encompasses the use of the said cycloalkane derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases.The compounds according to the invention are characterized by the general formula (I), ##STR1## wherein R represents hydrogen, C.sub.1-4 alkyl or hydroxyl,R.sup.1 stands for C.sub.1-12 alkyl,R.sup.2 and R.sup.3 each represents hydrogen, C.sub.1-12 alkyl or C.sub.2-12 alkenyl, orR.sup.2 and R.sup.3 together with the adjacent nitrogen atom form a 4- to 7-membered ring optionally comprising an oxygen, sulfur or a further nitrogen atom, which latter may carry a phenyl, benzyl or C.sub.1-4 alkyl substituent,R.sup.4 and R.sup.5 each stands for hydrogen, halogen or C.sub.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: June 4, 1996
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: Judit Bajnogel, Gabor Blasko, Zoltan Budai, Andras Egyed, Marton Fekete, Erika Karaffa, Tibor Mezei, Klara Reiter nee Esses, Gyula Simig, Katalin Szemeredi, Eniko Szirt nee Kiszelly
  • Basic ethers and process for the preparation thereof
    Patent number: 5486528
    Abstract: Novel basic ether of general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen, halogen or C.sub.1-4 alkoxy, or together they represent a 3,4-methylenedioxy group,R stands for C.sub.1-8 alkyl,R.sup.3 represents hydrogen, C.sub.1-4 alkyl or hydroxy,A is a valency bond or methylene group,R.sup.4 and R.sup.5 are independently hydrogen, C.sub.1-12 alkyl or C.sub.1-12 alkenyl, orR.sup.4 and R.sup.5 form together with the adjacent nitrogen atom 1-pyrrolidinyl, 1-piperidinyl, morpholino or 1-piperazinyl groups, stereo and optically active isomers and their possible mixtures, acid-addition salts and quaternary ammonium derivatives thereof. The basic ethers have antiulceric and anxiolytic activities.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: January 23, 1996
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: Judit Bajnogel, Gabor Blasko, Zoltan Budai, Eva Schmidt, Andras Egyed, Marton Fekete, Istvan Gacsalyi, Istvan Gyertyan, Tibor Mezei, Kalara Reiter nee Esses, Gyula Simig, Katalin Szemeredi, Enik Szirt nee Kiszelly